Isu-isu Terkini Keselamatan Ubat-edit

Isu-isu Terkini Keselamatan UbatSUI CHEE FAIPEGAWAI FARMASIKLINIK KESIHATAN LUYANG

INOVASI 2016

INOVASI 2016

INOVASI 2016

Mengenai Mesyuarat…





Isu Keselamatan.. Kenapa?• Terkini• Local vs Global data• ‘Under reporting’• Laporan ADR dari syarikat tidak mengandungi maklumat yang memuaskan untuk pihak MADRAC memberi ‘causality assessment’









Safety Issues for drugs involved• Dipeptidyl-peptidase-4 (DPP4) Inhibitors- Severe joint paint (Arthralgia)- Pancreatic cancer / pancreatitis• Useful information for other antidiabetic agents- Suspected adverse event of Metformin : Tinnutis

DPP4 inhibitors









DPP4i and pancreatic cancer

DPP4i and Pancreatitis

DPP4i Newest Update

























Safety Concern For Other Drugs• Statin- Muscular adverse effects – interaction with other drugs• Allopurinol

Statins and Muscle Injury



TEN - Toxic epidermal necrolysisDRESS – Drug reaction with Eosinophilia & Systemic Symptoms









NPCB Safety InformationMailing ListWHAT?Sign up to receive latest Malaysian drug safety information: • MADRAC Bulletin (3 editions annually) • Reaksi Drug Safety News (6 times annually) • Latest drug safety issue updates (as required)WHO?Open to all healthcare professionals (public and private sectors)HOW?Send an email with the Subject: BPFK Mailing List to:[email protected]

Thank You